LSKL, Inhibitor of Thrombospondin (TSP-1) [283609-79-0]
HY-P0299
Product group Proteins / Signaling Molecules
Overview
- SupplierMedChem Express
- Product NameLSKL, Inhibitor of Thrombospondin (TSP-1) [283609-79-0]
- Delivery Days Customer10
- CertificationResearch Use Only
- Estimated Purity99.77%
- Scientific DescriptionLSKL, Inhibitor of Thrombospondin (TSP-1) is a latency-associated protein (LAP)-TGFbeta derived tetrapeptide and a competitive TGF-beta1 antagonist. LSKL, Inhibitor of Thrombospondin (TSP-1) inhibits the binding of TSP-1 to LAP and alleviates renal interstitial fibrosis and hepatic fibrosis. LSKL, Inhibitor of Thrombospondin (TSP-1) suppresses subarachnoid fibrosis via inhibition of TSP-1-mediated TGF-beta1 activity, prevents the development of chronic hydrocephalus and improves long-term neurocognitive defects following subarachnoid hemorrhage (SAH). LSKL, Inhibitor of Thrombospondin (TSP-1) can readily crosse the blood-brain barrier.
- Storage Instruction-20°C,-80°C
- UNSPSC12352202